Online inquiry

IVTScrip™ mRNA-Human A4GALT, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK8710MR)

This product GTTS-WK8710MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the A4GALT protein. This product can be used in Endothelial cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001318038.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 53947
UniProt ID Q9NPC4
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human A4GALT, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK8710MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK26155MR IVTScrip™ mRNA-Human ARAF, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ARAF
GTTS-WK16041MR IVTScrip™ mRNA-Human ALPP, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ALPP
GTTS-WK6845MR IVTScrip™ mRNA-Human CD10, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA CD10
GTTS-WK8807MR IVTScrip™ mRNA-Human ACADM, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ACADM
GTTS-WK19620MR IVTScrip™ mRNA-Human ALK4, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ALK4
GTTS-WK23287MR IVTScrip™ mRNA-Human ART3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ART3
GTTS-WK15980MR IVTScrip™ mRNA-Human AKR7A3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AKR7A3
GTTS-WK16587MR IVTScrip™ mRNA-Human ALAS1, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ALAS1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW